Lumify for red eyes in glaucoma patients
Part of Eyes & vision clinical trials.
This study tests a red-eye relief drop called Lumify (brimonidine tartrate) in people with glaucoma who are already using brimonidine. It looks at whether Lumify changes eye redness, eye pressure, and eyelid position.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have been diagnosed with primary open angle glaucoma.
- You have been using a brimonidine eye drop (0.1%, 0.15%, or 0.2%) for more than 6 weeks and are still using it.
- You have NOT had any eye surgery in the past 6 months.
- You have never had eyelid surgery or Botox injections.
- You are NOT allergic to brimonidine, and you are not pregnant or a prisoner.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
This study uses a special camera (Brillouin microscopy) to measure how stiff your cornea is. It compares people with different types of glaucoma to those without glaucoma, helping researchers understand the link between corneal stiffness and eye pressure.
This trial tests two eye drops—Rhopressa (netarsudil) and timolol—at lowering eye pressure in people with open-angle glaucoma. The study uses a special camera to see if treatment helps protect the nerve cells in the back of the eye.
This study looks at whether certain glaucoma eye drops might help protect the nerve cells in your eye over time. If you've been using the same type of eye drop for a few years, researchers will review your past eye tests to see how your vision and eye health have changed.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.